Healthtech funding in June 2022
European Healthtech startup funding raised during June 2022.
In June 2022, 66 European Healthtech companies closed 67 funding rounds and raised €927M in equity funding (excluding debt and grants), up 40.6% versus June 2021. France led by capital raised, and Co-Founders was the most active investor. Data as of 20 Nov 2026.
Equity funding
€927M
+40.6% vs June 2021 · excl. debt & grants
Funding rounds
67
+36.7% vs June 2021
Companies
66
Top country
France
Rank among sectors
#4
8.4% of sector funding
Top-10 round share
61.1%
of disclosed capital
Top countries
by € raisedHealthtech — top countries by capital, June 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, June 2022 | |
|---|---|
| France | €300M |
| UK | €267M |
| Switzerland | €101M |
| Germany | €73M |
| Denmark | €68M |
| Sweden | €31M |
| Spain | €27M |
| Belgium | €20M |
Stage mix
by € raisedHealthtech — stage mix, June 2022 — interactive chart.
Data table
| Healthtech — stage mix, June 2022 | |
|---|---|
| Other | €380M |
| Series A | €195M |
| Series B | €174M |
| Series C | €100M |
| Seed | €79M |
| Pre-Seed | €100k |
Exits & M&A
4 Acquisition · 1 IPO5 exits · €2.9B disclosed.
| Norgine | Acquisition | Jun 2022 | €1.8B |
| SPT Labtech | Acquisition | Jun 2022 | €757M |
| Normax | IPO | Jun 2022 | €300M |
Top deals
largest disclosed rounds in June 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| Imcheck Therapeutics | Other | Jun 2022 | €96M |
| Proximie | Series C | Jun 2022 | €77M |
| Owkin | Series B | Jun 2022 | €74M |
| Diabeloop | Other | Jun 2022 | €70M |
| Immunos Therapeutics | Series B | Jun 2022 | €68M |
| Transition Bio | Series A | Jun 2022 | €47M |
| Evaxion Biotech | Other | Jun 2022 | €38M |
| Peptone | Other | Jun 2022 | €37M |
| Synklino | Series A | Jun 2022 | €30M |
| Moon Surgical | Series A | Jun 2022 | €30M |
| Birdie | Series B | Jun 2022 | €29M |
| Ariceum Therapeutics | Series A | Jun 2022 | €25M |
| Relation Therapeutics | Seed | Jun 2022 | €24M |
| BioVersys | Series C | Jun 2022 | €23M |
| LynxCare | Series A | Jun 2022 | €20M |
Top investors
most active in June 2022, by deal count- Co-Founders4 deals
- Sabadell Asabys3 deals
- Antler2 deals
- Bristol Myers Squibb2 deals
- btov Partners2 deals
- Dr. Schär AG2 deals
- Elaia2 deals
- Johnson & Johnson Innovation – JJDC2 deals
- Jonathan Milner2 deals
- Magnetic Ventures2 deals